rheumatoid arthritis. Arthritis Rheum, 36:S45. 
*27. Evans, C.H. and Robbins, P.D. (1994) Prospects for treating arthritis by gene 
therapy. J, Rheumatol. In Press. 
*28. Bandara, G., Mueller, G.M., Galea-Lauri, J,, Tindal, M.H., Georgescu, H.I., 
Suchanek, M.K., Hung, G.L., Glorioso, J.C., Robbins, P.D. and Evans, C.H. 
Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein 
by ex vivo gene transfer. Proc. Natl. Acad. Sci. USA 90:10764-10768. 
*29. Hung, G.L., Galea-Lauri, J., Mueller, G.M., Georgescu, H.I., Larkin, L.A., 
Suchanek, M.K., Tindal, M.H., Robbins, P.D. and Evans, C.H. (1994) Suppression of 
intra-articular resonses to interleukin-1 by transfer of the interleukin-1 receptor 
antagonist gene to synovium. Gene Therapy 1:64-69. 
*30. Hung, G.L., Robbins, P.D. and Evans, C.H. (1994) Synovial Cell Transplantation 
(E^., J.C. Glorioso) In Press, R.G. Landers, Georgetown, TX. 
31. Malyak, M., Swaney, R.E. and Arend, W.P. (1993) Synovial fluid interleukin-1 
receptor antagonist levels in rheumatoid arthritis and other arthropathies: potential 
contribution from synovial fluid neutrophils. Arthritis Rheum. 36:781-789, 
32. Miller, L.C., Lynch, E.A., Isa, S., Logan, J.W., Dinarello, C.A. and Steere, A.C. 
(1993) The balance of synovial fluid IL-1/3 and IL-lRa relates to recovery from attacks 
of Lyme arthritis. Lancet 341:146-148, 
33. Hess, E.V. (1988) Treatment In: Primer on the Rheumatic Diseases (Ed., H.R. 
Schumacher) 9th edition, pp. 93-96. Arthritis Foundation, Atlanta, GA. 
*34. Bandara, G., Robbins, P.D., Georgescu, H.I., Mueller, G.M., Gloriosos, J.C. and 
Evans, C.H. (1992) Gene transfer to synoviocytes: prospects for gene treatment of 
arthritis. DNA Cell Biol. 11:227-231. 
* - copies of these references are included as Appendix D 
[442] 
Recombinant DNA Research, Volume 19 
